About Us

Ra Medical Systems was founded in 2002 by Dean Irwin and Melissa Burstein to design, develop, and commercialize excimer lasers for the treatment of dermatologic and cardiovascular diseases. Its flagship product, Pharos, launched in 2004 and revolutionized the dermatology world with its technological advancements and game-changing business model of affordable ownership with unlimited use.

Staying true to the values upon which the company was founded, Ra Medical Systems continued to be a private, clinically-oriented, scientifically-driven organization, focusing on self-funding its growth organically and sustainably. Maintaining profitability year after year by strategic cost management while exponentially growing revenue from Pharos laser sales in the US and internationally, profits were reinvested internally to fund the development of its cardiovascular laser and catheters.

In 2012, the first patients were treated with Ra Medical Systems’ cardiovascular DABRA catheter and laser system in a pilot study conducted outside the United States.

Over the past decade, Pharos has helped hundreds of thousands of patients triumph over difficult-to-treat skin diseases and gain more confidence in their appearance and themselves. Ra Medical Systems’ Pharos has transformed their lives.

Today, Ra Medical Systems continues to make history as it conducts an investigational study of its cardiovascular DABRA catheter and laser system in the Unites States. The company believes this study can support a 510(k) medical device clearance and pave the way for patients all over the world to benefit.

Request a Call Back

Let us know how to get back to you.

Our Pledge To You

We, Ra Medical Systems, pledge to provide the highest quality, innovative technology that improves patients’ lives. We will do so with honesty and integrity, transparency in our actions, accountability for our products, and mindfulness of our responsibilities to our customers, their patients, and our shareholders.

A Legacy of Innovation

Ra Medical Systems was founded on three fundamental beliefs:

  • Excimer laser medicine could save and change lives for the better.
  • A totally new kind of company, built differently than those before it, could fulfill its potential.
  • The company must merge innovative science with pragmatic entrepreneurship, create a culture of smart, cost-effective decision making and personal accountability, and deliver better, safer, faster, and cheaper lasers and catheters.

This is the company we have built. This is the culture we have created. And this is the mission that drives us forward every day.


    Latest Articles

    • Interview with CEO of Ra Medical Systems

      To Access the article on MedGadget website click here. written by: Alice Ferng More than 200 million people worldwide, including approximately 8.5 million Americans, suffer from Peripheral Artery Disease (PAD). In the U.S. and Europe, PAD is responsible for around 240,000 amputations every year. Nearly a... Read More


    • Ra Medical Systems Receives FDA Clearance for Laser Ablation

      To access the article on Photonics Media's website click here. CARLSBAD, Calif. — In an effort to battle Peripheral Artery Disease (PAD), the leading cause of limb amputations, the FDA has granted market clearance to laser developer Ra Medical Systems Inc., makers of excimer lasers and... Read More


    • Ra Medical CEO Irwin Aims for Feb 2018 IPO

      To access the article on MassDevices' website click here.  In May, Ra Medical received a nod from the FDA for its DABRA arteriosclerosis laser, clearing it for use in the US. It was a decision the company had been waiting on for approximately 3 years, CEO Dean Irwin told MassDevice.com in an... Read More


    • DABRA Laser Ablates Blocked Arteries

      To access the article on MedGadget's website click here. Ra Medical, a company out of Carlsbad, California, received FDA clearance and is reporting the first commercial use of its DABRA laser-based arterial blockage ablation system. Unlike most other intravascular tools used for removing arterial plaque that... Read More